Cargando…

Early Vancomycin Concentrations and the Applications of a Pharmacokinetic Extrapolation Method to Recognize Sub-Therapeutic Outcomes

Vancomycin trough concentrations should be measured within 30 min of the next dose, but studies have shown that troughs are often measured too early, producing erroneous results that could lead to dosing errors. The purpose of this study was to identify the frequency of early trough measurements and...

Descripción completa

Detalles Bibliográficos
Autores principales: Santalo, Oscar, Baig, Umima, Poulakos, Mara, Brown, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419377/
https://www.ncbi.nlm.nih.gov/pubmed/28970410
http://dx.doi.org/10.3390/pharmacy4040037
_version_ 1783234217801416704
author Santalo, Oscar
Baig, Umima
Poulakos, Mara
Brown, Daniel
author_facet Santalo, Oscar
Baig, Umima
Poulakos, Mara
Brown, Daniel
author_sort Santalo, Oscar
collection PubMed
description Vancomycin trough concentrations should be measured within 30 min of the next dose, but studies have shown that troughs are often measured too early, producing erroneous results that could lead to dosing errors. The purpose of this study was to identify the frequency of early trough measurements and to evaluate whether pharmacokinetically extrapolating mistimed concentrations may locate sub-therapeutic concentrations. Vancomycin troughs were retrospectively reviewed. For troughs ≥10 mg/L and measured >0.5 h early, the true trough was estimated using pharmacokinetic extrapolation methods to identify sub-therapeutic outcomes. Differences ≥2 mg/L between the measured and estimated true trough level was considered to have potential clinical significance. Of 143 troughs evaluated, 62 (43%) were measured too early and 48 of those troughs were ≥10 mg/L. 25% of those 48 troughs were sub-therapeutic. The potential for a difference ≥2 mg/L between the measured and estimated true trough was found to be greatest when the measured trough was ≥10 mg/L, the patient’s creatinine clearance (CrCl) was ≥60 mL/min, and the timing error was ≥2 h. To increase the therapeutic utility of early vancomycin trough concentrations, estimated true troughs can be determined by extrapolating measured values based on the time difference and CrCl.
format Online
Article
Text
id pubmed-5419377
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-54193772017-09-29 Early Vancomycin Concentrations and the Applications of a Pharmacokinetic Extrapolation Method to Recognize Sub-Therapeutic Outcomes Santalo, Oscar Baig, Umima Poulakos, Mara Brown, Daniel Pharmacy (Basel) Article Vancomycin trough concentrations should be measured within 30 min of the next dose, but studies have shown that troughs are often measured too early, producing erroneous results that could lead to dosing errors. The purpose of this study was to identify the frequency of early trough measurements and to evaluate whether pharmacokinetically extrapolating mistimed concentrations may locate sub-therapeutic concentrations. Vancomycin troughs were retrospectively reviewed. For troughs ≥10 mg/L and measured >0.5 h early, the true trough was estimated using pharmacokinetic extrapolation methods to identify sub-therapeutic outcomes. Differences ≥2 mg/L between the measured and estimated true trough level was considered to have potential clinical significance. Of 143 troughs evaluated, 62 (43%) were measured too early and 48 of those troughs were ≥10 mg/L. 25% of those 48 troughs were sub-therapeutic. The potential for a difference ≥2 mg/L between the measured and estimated true trough was found to be greatest when the measured trough was ≥10 mg/L, the patient’s creatinine clearance (CrCl) was ≥60 mL/min, and the timing error was ≥2 h. To increase the therapeutic utility of early vancomycin trough concentrations, estimated true troughs can be determined by extrapolating measured values based on the time difference and CrCl. MDPI 2016-11-10 /pmc/articles/PMC5419377/ /pubmed/28970410 http://dx.doi.org/10.3390/pharmacy4040037 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Santalo, Oscar
Baig, Umima
Poulakos, Mara
Brown, Daniel
Early Vancomycin Concentrations and the Applications of a Pharmacokinetic Extrapolation Method to Recognize Sub-Therapeutic Outcomes
title Early Vancomycin Concentrations and the Applications of a Pharmacokinetic Extrapolation Method to Recognize Sub-Therapeutic Outcomes
title_full Early Vancomycin Concentrations and the Applications of a Pharmacokinetic Extrapolation Method to Recognize Sub-Therapeutic Outcomes
title_fullStr Early Vancomycin Concentrations and the Applications of a Pharmacokinetic Extrapolation Method to Recognize Sub-Therapeutic Outcomes
title_full_unstemmed Early Vancomycin Concentrations and the Applications of a Pharmacokinetic Extrapolation Method to Recognize Sub-Therapeutic Outcomes
title_short Early Vancomycin Concentrations and the Applications of a Pharmacokinetic Extrapolation Method to Recognize Sub-Therapeutic Outcomes
title_sort early vancomycin concentrations and the applications of a pharmacokinetic extrapolation method to recognize sub-therapeutic outcomes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419377/
https://www.ncbi.nlm.nih.gov/pubmed/28970410
http://dx.doi.org/10.3390/pharmacy4040037
work_keys_str_mv AT santalooscar earlyvancomycinconcentrationsandtheapplicationsofapharmacokineticextrapolationmethodtorecognizesubtherapeuticoutcomes
AT baigumima earlyvancomycinconcentrationsandtheapplicationsofapharmacokineticextrapolationmethodtorecognizesubtherapeuticoutcomes
AT poulakosmara earlyvancomycinconcentrationsandtheapplicationsofapharmacokineticextrapolationmethodtorecognizesubtherapeuticoutcomes
AT browndaniel earlyvancomycinconcentrationsandtheapplicationsofapharmacokineticextrapolationmethodtorecognizesubtherapeuticoutcomes